2015-2016 Influenza Season Week 25 ending June 25, 2016
All data are preliminary and may change as more reports are received.
U.S. Virologic Surveillance:
WHO and NREVSS collaborating laboratories, which include both public health and clinical laboratories located in all 50 states, Puerto Rico, and the District of Columbia, report to CDC the total number of respiratory specimens tested for influenza and the number positive for influenza by virus type. In addition, public health laboratories also report the influenza A subtype (H1 or H3) and influenza B lineage information of the viruses they test and the age or age group of the persons from whom the specimens were collected.
Additional virologic data can be found at: http://gis.cdc.gov/grasp/fluview/fluportaldashboard.html and http://gis.cdc.gov/grasp/fluview/flu_by_age_virus.html.
View National and Regional Level Graphs and Data | View Chart Data | View Full Screen | View PowerPoint Presentation
View National and Regional Level Graphs and Data | View Chart Data | View Full Screen | View PowerPoint Presentation
Novel Influenza A Viruses:
Two human infections with novel influenza A viruses were reported to CDC during week 25.
One human infection with a novel influenza A virus was reported by the state of Wisconsin. The person was infected with an influenza A (H1N2) variant (H1N2)v virus. The patient was hospitalized as a result of their illness, and continues to recover. Direct contact with swine in the week preceding illness onset was reported. No ongoing community transmission has been detected.
One human infection with a novel influenza A virus was reported by the state of Minnesota. In April 2016, the person was infected with an H1N2v virus. The patient was not hospitalized and has fully recovered from their illness. No human-to-human transmission has been identified and the case reported close contact with swine in the week prior to illness onset.
Early identification and investigation of human infections with novel influenza A viruses are critical so that the risk of infection can be more fully appreciated and appropriate public health measures can be taken. Additional information on influenza in swine, variant influenza infection in humans, and strategies to interact safely with swine can be found at http://www.cy118119.com/flu/swineflu/index.htm.
Pneumonia and Influenza (P&I) Mortality Surveillance:
Rapid tracking of pneumonia and influenza-associated deaths is done through two systems, the National Center for Health Statistics (NCHS) Mortality Surveillance System and the 122 Cities Mortality Reporting System. NCHS mortality surveillance data are presented by the week the death occurred and P&I percentages are released two weeks after the week of death to allow for collection of enough data to produce a stable P&I percentage. Users of the data should not expect the two systems to produce the same percentages, and the percent P&I deaths from each system should be compared to the corresponding system-specific baselines and thresholds.
NCHS Mortality Surveillance Data:
Based on NCHS mortality surveillance data available on June 30, 2016, 5.7% of the deaths occurring during the week ending June 11, 2016 (week 23) were due to P&I. This percentage is below the epidemic threshold of 6.6% for week 23.
Region and state-specific data are available at http://www.cy118119.com/flu/weekly/nchs.htm.
View Regional and State Level Data | View Chart Data | View Full Screen | View PowerPoint Presentation
122 Cities Mortality Reporting System:
During week 25, 5.8% of all deaths reported through the 122 Cities Mortality Reporting System were due to P&I. This percentage was below the epidemic threshold of 6.1% for week 25.
View Full Screen | View PowerPoint Presentation
Influenza-Associated Pediatric Mortality:
No influenza-associated pediatric deaths were reported to CDC during week 25. A total of 77 influenza-associated pediatric deaths have been reported during the 2015-2016 season.
Additional data can be found at: http://gis.cdc.gov/GRASP/Fluview/PedFluDeath.html.
Influenza-Associated Hospitalizations:
The Influenza Hospitalization Surveillance Network (FluSurv-NET) conducts all age population-based surveillance for laboratory-confirmed influenza-related hospitalizations in select counties in the Emerging Infections Program (EIP) states and Influenza Hospitalization Surveillance Project (IHSP) states. Additional FluSurv-NET data can be found at: http://gis.cdc.gov/GRASP/Fluview/FluHospRates.html and http://gis.cdc.gov/grasp/fluview/FluHospChars.html.
Outpatient Illness Surveillance:
Nationwide during week 25, 0.9% of patient visits reported through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to influenza-like illness (ILI). This percentage is below the national baseline of 2.1%.
(ILI is defined as fever (temperature of 100擄F [37.8擄C] or greater) and cough and/or sore throat.)
Additional data are available at http://gis.cdc.gov/grasp/fluview/fluportaldashboard.html.
View National and Regional Level Graphs and Data | View Chart Data | View Full Screen | View PowerPoint Presentation
Additional National and International Influenza Surveillance Information
FluView Interactive: FluView includes enhanced web-based interactive applications that can provide dynamic visuals of the influenza data collected and analyzed by CDC. These FluView Interactive applications allow people to create customized, visual interpretations of influenza data, as well as make comparisons across flu seasons, regions, age groups and a variety of other demographics. To access these tools, visit http://www.cy118119.com/flu/weekly/fluviewinteractive.htm.
U.S. State and local influenza surveillance: Click on a jurisdiction below to access the latest local influenza information.
World Health Organization: Additional influenza surveillance information from participating WHO member nations is available through FluNet and the Global Epidemiology Reports.
WHO Collaborating Centers for Influenza located in Australia, China, Japan, the United Kingdom, and the United States (CDC in Atlanta, Georgia).
Europe: For the most recent influenza surveillance information from Europe, please see WHO/Europe and the European Centre for Disease Prevention and Control at http://www.flunewseurope.org/
Public Health Agency of Canada: The most up-to-date influenza information from Canada is available at http://www.phac-aspc.gc.ca/fluwatch/
Public Health England: The most up-to-date influenza information from the United Kingdom is available at https://www.gov.uk/government/statistics/weekly-national-flu-reports
Any links provided to non-Federal organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization web pages found at these links.
An overview of the CDC influenza surveillance system, including methodology and detailed descriptions of each data component, is available at: http://www.cy118119.com/flu/weekly/overview.htm.
--------------------------------------------------------------------------------